ACXP vs MSFT: Which Stock is Better?
Side-by-side comparison of Acurx Pharmaceuticals Inc and Microsoft Corp in 2026
ACXP
Acurx Pharmaceuticals Inc
$2.57
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | ACXP | MSFT | Winner |
|---|---|---|---|
| Market Cap | $5.99M | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 0.0% | 68.8% | MSFT |
Analyze ACXP
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACXP or MSFT a better investment?
Comparing ACXP and MSFT: Acurx Pharmaceuticals Inc has a market cap of $5.99M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACXP and MSFT?
ACXP (Acurx Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACXP or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACXP or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for ACXP.
Which company is more profitable: ACXP or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 0.0% for ACXP.
Which is the larger company: ACXP or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $5.99M for ACXP.
Should I buy ACXP or MSFT in 2026?
Both ACXP and MSFT have investment merit. ACXP trades at $2.57 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACXP and MSFT stock?
Key differences: Market Cap ($5.99M vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (0.0% vs 68.8%).